Genetic alteration of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2A and 2B (MEN 2A and MEN 2B), familial medullary thyroid carcinoma (FMTC) and Hirschprung's disease. Oncogenically activated RET has also been demonstrated in sporadic medullary thyroid tumors, which in some cases show somatic missense mutations. We have recently described a complex 9 bp deletion in RET exon 11 in a single case of sporadic MTC. In order to determine the prevalence of this mutation among sporadic MTC tumors, we have now analysed 15 cases and ®ve normal controls by PCR-based nonradioactive single-strand conformational polymorphism analysis (PCR-SSCP) and fragment size analysis of exon 11. DNA was extracted from microdissected tumor tissue or normal cells and subjected to nested PCR prior to analysis. A markedly divergent SSCP pattern and a PCR fragment 9 bp shorter than normal were demonstrated in 14 of the 15 MTC tumors. Sequencing revealed the deletion of nine bases encompassing a key cysteine at codon 634, often altered in MEN 2A. Four lymphocyte controls and normal thyroid tissue from one patient failed to show the deletion. Several factors in the DNA sequence environment immediately surrounding the deletions, including an extended inverted repeat, several direct repeats and a so-called symmetric element suggest that the deletional events may be non-random.
Introduction
The RET proto-oncogene encodes a transmembrane receptor-tyrosine kinase, recently shown to be activated by glial cell line-derived neurotrophic factor (GDNF), possibly through interaction with the GDNF receptor a (Durbec et al., 1996; Jing et al., 1996; Trupp et al., 1996) . Four hereditary diseases with autosomal dominant inheritance have been tied to mutations in the RET gene: familial medullary carcinoma (FMTC) (Farndon et al., 1986; Jackson and Norum, 1989; Lairmore and Wells, 1993) , multiple endocrine neoplasia type 2A (MEN 2A) in which patients develop MTC and pheochromocytoma (Sipple, 1961) , MEN 2B which shows these two tumors in conjunction with skeletal abnormalities and ganglioneuromas of the gastrointestinal tract (Carney et al., 1976; Schimke et al., 1968) , and Hirschprung's disease, a congenital lack of enteric plexus neurons resulting in intestinal immobility.
In FMTC, germ-line missense mutations are found in exons 10, 11, 13, and 14 of the RET proto-oncogene (Bolino et al., 1995; Donis-Keller et al., 1993; Eng et al., 1995; Schuenecker et al., 1994) . MEN 2A is associated with point mutations in exons 10 and 11, while MEN 2B and a small proportion of sporadic MTC show speci®c missense mutations in exon 16 (Donis-Keller et al., 1993; Eng et al., 1995; Hofstra et al., 1994; Mulligan et al., 1993) . In addition, the deletion of six bases removing a cysteine at codon 630 or 634 has been reported in two separate cases of sporadic MTC. (S Dou and H Donis-Keller, personal communication; Kimura et al., 1995) .
We have recently reported the deletion of nine base pairs in RET exon 11 discovered in a case of sporadic MTC. The deletion causes the loss of three codons (Leu 633 -Cys 634 -ARG 635 ) and the substitution of two (Glu 632 to Ser and Thr 636 to Ser), producing a characteristic polymerase chain reaction-based singlestrand DNA conformation polymorphism (PCR-SSCP) pattern (Alemi et al., 1996) . Here we report the occurrence of this same complex deletion in 14 of 15 cases of sporadic MTC, as revealed by PCR-SSCP, uorescent fragment size analysis (GeneScan) and DNA sequencing.
Results

PCR-SSCP
A PCR-SSCP pattern indicating the previously described complex 9 bp deletion in exon 11 was found in 14 of 15 sporadic MTC cases. Representative results of the nonradioactive PCR-SSCP analysis are shown in Figure 1 . Tumor samples (lanes 1 ± 15) demonstrated a highly divergent heterozygous SSCP pattern as compared to normal thyroid tissues from patient 12 (lane 16) and four normal lymphocyte controls (lanes 17 ± 20).
Fluorescent fragment size analysis of PCR product by GeneScan
To determine the exact sizes of the PCR products generated, amplicons of the 20 DNA samples mentioned above (15 MTC tumors and ®ve controls) were assessed using GeneScan. Chromatograms of the GeneScan analysis are shown in Figure 2 . Products derived from normal thyroid tissue gave one sharp peak of¯uorescence (Figure 2 , case 16) corresponding to the normal allele at 192 bp, whereas amplicons from 14 of 15 sporadic MTC cases yielded both the normal 192 bp peak and a 9 bp shorter fragment at 183 bp (Figure 2, 1 ± 6 and 8 ± 15, Table 1 ). One case of MTC and the normal lymphocyte controls showed normal fragment patterns (Figure 2 , cases 7 and 17 ± 20) respectively.
Sequencing
To con®rm the results of PCR-SSCP and GeneScan, we then sequenced PCR product from four positive cases (cases 1, 2, 5 and 12) one negative case (case 7) and normal tissue from patient 12 (case 16). Sequencing of the sense and antisense strands of the exon 11 PCR product revealed the deletion of nine bases at positions 1825 and 1830-7 (Takahashi et al., 1988) within the Cys-rich extracellular domain in the four positive cases (Figure 3 ). This alteration results in the loss of codons 633 ± 635 (Leu-Cys-Arg), including a Cys at 634 reported to show missense mutation in MEN 2A (Mulligan et al., 1993) . In addition, Glu at codon 632 and Thr at 636 are both altered to Ser (Figure 3 ). The sequence of the mutant allele was seen as a background chromatogram nine bases out of phase, beginning at the deleted region and continuing to the end of the fragment. No exon 11 deletions were found in case 7 or case 16.
Discussion
We have recently described a complex deletion in RET exon 11 associated with an aggressive case of sporadic MTC. In order to determine the prevalence of this mutation among sporadic MTC tumors, we have now screened a number of cases using PCR-SSCP, GeneScan and direct sequencing. This analysis indicates that the same deletion is present in a large proportion of unrelated cases, suggesting that this speci®c deletion is a common occurrence in sporadic MTC. When analysing sporadic tumors, it is important to consider the relative amount of DNA contributed by tumor cells. Depending on the relative number of neoplastic cells in a given tumor, the proportion of mutant to normal DNA would be expected to dier from case to case, and is critical to the detection of the mutation; a low ratio of tumor:normal DNA could (560 nm) is shown on the Y-axis and PCR fragment size on the X-asis (given in base pairs) for each PCR product. Case numbers coincide with Table 1 Figure 3 Partial sequences of normal RET exon 11 and the deletion mutant as determined by DNA sequencing of PCR product. Deleted bases are represented by asterisks, codon numbers are shown above and below the sequences theoretically give a false negative result due to exponential ampli®cation of the normal allele. This is not the case in detecting germ-line mutations, as the mutant allele is always present at a 1 : 1 ratio. In order to test this, we used non-nested PCR to amplify exon 11 from sporadic MTC DNA known to contain the 9 bp deletion (Alemi et al., 1996) diluted serially with normal lymphocyte DNA. SSCP and GeneScan showed that the mutant bands disappeared at a tumor:normal DNA ratio of 1 : 7 an 1 : 15, respectively (data not shown). The combination of microdissection and nested PCR was therefore used to (1) increase the proportion of tumor cell DNA relative to that from normal thyroid cells and (2) adequately amplify the resulting small quantities of DNA. Three dierent analytical methods were used to obtain dierent types of information: PCR-SSCP is capable of detecting the full spectrum of genetic alterations in a given sequence, but is uninformative as to the nature of the mutation; GeneScan gives the exact size of the fragments, in this case demonstrating that the mutated product was 9 bp shorter than the normal allele in all positive tumors; and direct sequencing de®nitively characterizes the mutation, which is identical in the tumors of cases 1, 2, 5, and 12. By combining microdissection, nested PCR and these three dierent analytical approaches (SSCP, GeneScan and direct sequencing), we have been able to prove the identity of the 9 bp deletion (1825 del G + 1830del GTGCCGCA, codons 633 ± 635) and its presence in 14 of the 15 sporadic MTC tumors studied.
The identical, complex nature of the deletions found here suggests that non-random processes may lead to their occurrence. We have therefore examined the DNA sequence in and adjacent to the deletions in search of predisposing factors. In bacterial systems, it has been demonstrated that inverted repeat sequences (palindromes) are preferentially deleted spontaneously (Albertini et al., 1982; Brunier et al., 1988; DasGupta et al., 1987; Galas, 1978; Schaaper et al., 1986) while direct repeats have been implicated in the occurrence of deletions in a number of viral systems (Singer and Westly, 1988) . In humans, several factors in the local DNA sequence environment of small deletions (1 ± 20 bp) linked to inherited and sporadic diseases have been shown to correlate to the deletions, including short direct repeats (2 ± 8 bp), inverted repeats, symmetric elements (e.g. AGTGCTGA in which loss of the C leaves a sequence symmetric about the central G) and the presence of a speci®c concensus sequence (TGA/GA/GG/TA/C) (Krawczak and Cooper, 1991) . Also, Yamakawa-Kobayashi et al., 1993 have found several inverted repeat sequences around the region of a complex nucleotide deletion-substitution in the LDL receptor gene, associated with familial hypercholesterolemia (Yamakawa-Kobayashi et al., 1993). As a generative mechanism for this complex mutation, they propose that these inverted repeat sequences form a hairpin-loop structure during replication, and that the deletional event occurs within this structure.
A number of the factors mentioned here are also present in the vicinity of the 9 bp RET compound deletion, as demonstrated in Figure 4a . The 8 bp deletion itself is palindromic, and is part of a larger imperfect palindrome (Figure 4b ) that could produce a hairpin-loop with relatively high thermodynamic stability under physiological conditions (DG=713.4 kcal/mol). The ®rst bases of the 8 bp deletion are also part of a 6 bp direct repeat (CTGTGC), and four bases ®t the six base concensus sequence (TGCCGC). The single base pair deletion at position 1825 is within the latter of two immediate direct repeats (CGA CGA), and when deleted leaves a 7 bp symmetric element (CGACAGC, Figure 4) .
Why then would both deletions be seen in such a large proportion of sporadic tumors? Either of these two deletions alone would result in a frameshift mutation with subsequent loss of RET protein function, and thus no neoplastic phenotype. However, when both occur in the same allele, the mutation becomes in-frame, allowing for the formation of mutant mRNA and protein. It has been demonstrated that non-conserved point mutation at the Cys 634 codon causes constitutive activation of the tyrosine kinase of RET, and transfection of ®broblasts with the Cys 634 -mutated construct gives a transformed phenotype (Santoro et al., 1995) . It is thus plausible that loss of this Cysteine codon through deletion could also result in constitutive activation and neoplasia, possibilities which are presently under investigation in our laboratory.
Previous studies have demonstrated several types of RET mutations in conjunction with sporadic MTC, although in most cases no abnormality has been found (Takahashi, 1995) . The most commonly seen mutations alter codons 918, 883 or 768, each in a small proportion of cases (Donis-Keller, 1995; Lloyd, 1995) . However, two reports have mentioned the deletion of 6 bp including codon 630 or 634, each in a single case of sporadic MTC (Donis-Keller, 1995; Kimura et al., 1995) .
The divergence between our results and those previously reported is perplexing. It may depend on ethnic dierences (ours was a homogeneous Swedish material) or the dilution of mutant alleles by normal DNA in other studies. As the analysis of sequence data is often targeted toward detection of point mutations, a low amplitude, phase shifted mutant sequence may easily be interpreted as background. Careful analysis of a large, multi-ethnic material will be necessary to evaluate this issue.
Materials and methods
Patient material
Fifteen cases were chosen randomly from among formalin ®xed, paran embedded tumors demonstrating morphological characteristics typical of MTC and known to be sporadic by review of the patients' clinical records. The time of surgery ranged from 1957 to 1992. Patients were operated on at hospitals throughout Sweden, and all are believed to be of Swedish descent. The tumor cells stained for the C-cell markers chromogranin A and calcitonin (Boehringer Mannheim) in routine immunohistochemistry. Parallel sections from these blocks were used for DNA extraction.
DNA extraction
Genomic DNA was isolated from one 10 mm thick section of each tumor tissue block. The sections were deparaffinized with xylene and washed in absolute ethanol. These sections were stained with hematoxylin-eosin. To enrich for tumor cells, microdissection was performed under a microscope using a ®ne needle. Tumor cells were dissected free from surrounding normal tissue, transferred to microcentrifuge tubes and treated with 500 mg/ml proteinase K in 30 ml digestion buer (50 mM KCl, 10 mM TrisHCl pH 8.3) at 568C overnight. The enzyme was then inactivated by boiling for 10 min. This method increases the proportion of tumor cells, but a number of normal cells are always present. Controls consisted of DNA extracted from normal thyroid tissues from one MTC patient and normal blood lymphocytes from healthy donors. For each sample, the same DNA extract was used to perform PCR for SSCP, GeneScan and DNA sequencing.
Nested PCR
Oligonucleotide primers for ampli®cation of exon 11 of the RET proto-oncogene were chosen from previously published data (Donis-Keller et al., 1993) . PCR fragments were ampli®ed from 5 ml genomic tumor or control DNA (approx 33 mg/ml) in a 30 ml mixture containing 0.2 mM dNTP, 0.5 mM each primer, 2.5 mM Mg 2+ , 50 mM KCl, 10 mM Tris-HCl pH 8.3, 0.5 U Taq DNA polymerase (Perkin Elmer). The protocol consisted of initial denaturation at 958C for 3 min, 20 cyles of denaturation at 948C for 1 min, annealing at 658C for 1 min, and extension at 728C for 1 min, followed by a ®nal extension at 728C for 10 min. The expected size of the ampli®cation product is 234 bp. Reampli®cation of 3 ml aliquots of the ampli®ed mixture was performed using oligonucleotide primers internal to the original primers (5' GTG CCA AGC CTC ACA CCA CCC 3' for the forward and 5' GCG GGC CTC CGG AAG GTC AT 3' for the reverse) with 15 cycles of 948C for 1 min, 658C for 1 min and 728C for 1 min linked to 20 cycles of 948C for 1 min, 638C for 1 min, and 728C for 1 min, with a ®nal extension at 728C for 10 min. The expected size of the ®nal ampli®cation product is 192 bp.
SSCP analysis
One ml aliquots of PCR-mixture in 1 ml of denaturing solution (0.05% bromophenol blue, 0.05% xylene cyanol in formamide) was heated to 958C for 5 min, followed by rapid cooling on ice. One ml of the denatured sample was separated using a Phast Gel system electrophoresis apparatus (Pharmacia LKB Biotechnology, Uppsala, Sweden) on premade 4 ± 15% gradient polyacrylamide gels under non-denaturing conditions. The instrument was programmed with a pre-run at 100 Vh followed by 50 Vh at 168C. The gels were silver stained according to the manufacturer's instructions (Pharmacia LKB, Biotechnology).
Fluorescent fragment size analysis (GeneScan)
For automated¯uorescent fragment analysis, exon 11 PCR products were generated using the primer pairs described above, the nested forward primer labeled with HEX (6-carboxy-2', 4', 7' 4, 7-Hexachloro¯uorescene) at the 5' end. The PCR product was diluted 1 : 4 in distilled water and 1 ml was added to a mixture of 12 ml deionized formamide and 0.5 ml molecular size standard (TAMRA GS-500, Applied Biosystems Inc.). The samples were denatured at 908C for 2 min and placed on ice, after which they were loaded onto a 3% GeneScan polymer containing 6.6 M urea in an ABI Prism 310 genetic analyser (Applied Biosystems Inc.). The electrophoresis was run for 18 min and the¯uorescent signals analysed using the GeneScan Analysis software package (Applied Biosystems Inc.), which assigns DNA chain length in bases in relation to the size markers. The resolution of the method is reported by the manufacturer to be two residues.
DNA sequencing
Exon 11 DNA ampli®ed as for SSCP was puri®ed by electrophoretic separation on 1% agarose gels followed by ion-exchange isolation from excised bands of approximately 192 bp (Jetsorb, Genomed Inc, N.C.). Approximately 30 ng/ml of puri®ed DNA was used as template. Fluorescence-based dideoxy terminator cycle sequencing was performed using a Taq polymerase based kit (Applied Biosystems Inc., Foster city, USA) according to the manufacturer's protocol, and an automated DNA sequencer (Model 310, Applied Biosystems Inc.). The sequence of both sense and antisense strands of the PCR products was determined.
